MedPath

The Effect of Royal Jelly on Gene Expression of Some Immune Factors in People Infected with Hepatitis B

Phase 1
Conditions
Hepatitis B.
Chronic viral hepatitis
Registration Number
IRCT20210620051640N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Infected with Hepatitis B for more than six months

Exclusion Criteria

Infected by other viruses
Suffering from immune related diseases
Receiving drugs that affect the immune system

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gene expression of some molecules of S100 families, apoptosis, inflammation and chemokines is measured in patients with hepatitis B before and after oral administration of Royal Jelly. Timepoint: Before and after taking Royal Jelly orally. Method of measurement: Real time PCR assay.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath